Cargando…
Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in p...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718360/ https://www.ncbi.nlm.nih.gov/pubmed/30660541 http://dx.doi.org/10.1016/j.jcmg.2018.10.028 |
_version_ | 1783447708963438592 |
---|---|
author | Borlotti, Alessandra Jerosch-Herold, Michael Liu, Dan Viliani, Dafne Bracco, Alessia Alkhalil, Mohammad De Maria, Giovanni Luigi Channon, Keith M. Banning, Adrian P. Choudhury, Robin P. Neubauer, Stefan Kharbanda, Rajesh K. Dall’Armellina, Erica |
author_facet | Borlotti, Alessandra Jerosch-Herold, Michael Liu, Dan Viliani, Dafne Bracco, Alessia Alkhalil, Mohammad De Maria, Giovanni Luigi Channon, Keith M. Banning, Adrian P. Choudhury, Robin P. Neubauer, Stefan Kharbanda, Rajesh K. Dall’Armellina, Erica |
author_sort | Borlotti, Alessandra |
collection | PubMed |
description | OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in patients with reperfused ST-segment elevation myocardial infarction (STEMI). Clinical trials have focused on cardioprotective strategies to maintain microvascular functionality, but there is a need for a noninvasive test to determine their efficacy. METHODS: A total of 64 STEMI patients post–primary percutaneous coronary intervention underwent 3-T CMR scans acutely and at 6 months (6M). The protocol included cine function, T(2)-weighted edema imaging, pre-contrast T1 mapping, rest first-pass perfusion, and late gadolinium enhancement imaging. Segmental MBF, corrected for rate pressure product (MBF(cor)), was quantified in remote, edematous, and infarcted myocardium. RESULTS: Acute MBF(cor) was significantly reduced in infarcted myocardium compared with remote MBF (MBF(infarct) 0.76 ± 0.20 ml/min/g vs. MBF(remote) 1.02 ± 0.21 ml/min/g, p < 0.001), but it significantly increased at 6M (MBF(infarct) 0.76 ± 0.20 ml/min/g acute vs. 0.85 ± 0.22 ml/min/g at 6M, p < 0.001). On a segmental basis, acute MBF(cor) had incremental prognostic value for infarct size at 6M (odds of no LGE at 6M increased by 1.4:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)) and functional recovery (odds of wall thickening >45% at 6M increased by 1.38:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)). In subjects with coronary flow reserve >2 or index of myocardial resistance <40, acute MBF was associated with long-term functional recovery and was an independent predictor of infarct size reduction. CONCLUSIONS: Acute MBF by CMR could represent a novel quantitative imaging biomarker of microvascular reversibility, and it could be used to identify patients who may benefit from more intensive or novel therapies. |
format | Online Article Text |
id | pubmed-6718360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67183602019-09-06 Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study Borlotti, Alessandra Jerosch-Herold, Michael Liu, Dan Viliani, Dafne Bracco, Alessia Alkhalil, Mohammad De Maria, Giovanni Luigi Channon, Keith M. Banning, Adrian P. Choudhury, Robin P. Neubauer, Stefan Kharbanda, Rajesh K. Dall’Armellina, Erica JACC Cardiovasc Imaging Article OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in patients with reperfused ST-segment elevation myocardial infarction (STEMI). Clinical trials have focused on cardioprotective strategies to maintain microvascular functionality, but there is a need for a noninvasive test to determine their efficacy. METHODS: A total of 64 STEMI patients post–primary percutaneous coronary intervention underwent 3-T CMR scans acutely and at 6 months (6M). The protocol included cine function, T(2)-weighted edema imaging, pre-contrast T1 mapping, rest first-pass perfusion, and late gadolinium enhancement imaging. Segmental MBF, corrected for rate pressure product (MBF(cor)), was quantified in remote, edematous, and infarcted myocardium. RESULTS: Acute MBF(cor) was significantly reduced in infarcted myocardium compared with remote MBF (MBF(infarct) 0.76 ± 0.20 ml/min/g vs. MBF(remote) 1.02 ± 0.21 ml/min/g, p < 0.001), but it significantly increased at 6M (MBF(infarct) 0.76 ± 0.20 ml/min/g acute vs. 0.85 ± 0.22 ml/min/g at 6M, p < 0.001). On a segmental basis, acute MBF(cor) had incremental prognostic value for infarct size at 6M (odds of no LGE at 6M increased by 1.4:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)) and functional recovery (odds of wall thickening >45% at 6M increased by 1.38:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)). In subjects with coronary flow reserve >2 or index of myocardial resistance <40, acute MBF was associated with long-term functional recovery and was an independent predictor of infarct size reduction. CONCLUSIONS: Acute MBF by CMR could represent a novel quantitative imaging biomarker of microvascular reversibility, and it could be used to identify patients who may benefit from more intensive or novel therapies. Elsevier 2019-09 /pmc/articles/PMC6718360/ /pubmed/30660541 http://dx.doi.org/10.1016/j.jcmg.2018.10.028 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Borlotti, Alessandra Jerosch-Herold, Michael Liu, Dan Viliani, Dafne Bracco, Alessia Alkhalil, Mohammad De Maria, Giovanni Luigi Channon, Keith M. Banning, Adrian P. Choudhury, Robin P. Neubauer, Stefan Kharbanda, Rajesh K. Dall’Armellina, Erica Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title_full | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title_fullStr | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title_full_unstemmed | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title_short | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study |
title_sort | acute microvascular impairment post-reperfused stemi is reversible and has additional clinical predictive value: a cmr oxami study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718360/ https://www.ncbi.nlm.nih.gov/pubmed/30660541 http://dx.doi.org/10.1016/j.jcmg.2018.10.028 |
work_keys_str_mv | AT borlottialessandra acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT jeroschheroldmichael acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT liudan acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT vilianidafne acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT braccoalessia acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT alkhalilmohammad acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT demariagiovanniluigi acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT channonkeithm acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT banningadrianp acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT choudhuryrobinp acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT neubauerstefan acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT kharbandarajeshk acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy AT dallarmellinaerica acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy |